Northwestern Mutual Wealth Management
FNCH

Northwestern Mutual Wealth Management’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio FNCH Stock Details FNCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-141
Closed -$509 – 3890
2023
Q4 		$509 Buy
+141
New +$556 ﹤0.01% 3272
2023
Q1 		– Sell
-20
Closed -$288 – 3646
2022
Q4 		$288 Hold
20
– – ﹤0.01% 3164
2022
Q3 		$1K Hold
20
– – ﹤0.01% 3053
2022
Q2 		$2K Hold
20
– – ﹤0.01% 2970
2022
Q1 		$3K Hold
20
– – ﹤0.01% 2884
2021
Q4 		$6K Hold
20
– – ﹤0.01% 2761
2021
Q3 		$8K Buy
+20
New +$8.53K ﹤0.01% 2555

Other funds holding FNCH

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northwestern Mutual Wealth Management's FNCH Position: Q1 2024 in Review

Northwestern Mutual Wealth Management sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q1 2024, closing a stake of 141 shares — an estimated $509 sold.

Northwestern Mutual Wealth Management first reported a position in FNCH in Q3 2021 and held it in 7 quarters. The position peaked at $8K in Q3 2021. 11 funds tracked by Wall St. Rank hold FNCH as of Q1 2024.

  • Northwestern Mutual Wealth Management reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 141 Finch Therapeutics Group, Inc. Common Stock shares in Q1 2024, an estimated $509.
  • Northwestern Mutual Wealth Management first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • Northwestern Mutual Wealth Management's Finch Therapeutics Group, Inc. Common Stock position peaked at $8K in Q3 2021.
  • 11 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q1 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.